Publications

Filters
April 2, 2019

Antitumor activity of the novel oral highly selective Wee1 inhibitor Debio 0123

Read more
December 14, 2018

DEBIO 1143, an IAP inhibitor, reverses ovarian cancer cells carboplatin resistance and triggers apoptotic or necroptotic cell death

Read more
December 2, 2018

Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in…

Read more
October 23, 2018

SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer

Read more
April 21, 2018

Cellular pharmacokinetics (accumulation, subcellular distribution, efflux) of the FabI inhibitor Debio 1452 in J774 macrophages

Read more
April 21, 2018

Staphylococcal-selective antibiotic afabicin preserves the human gut microbiota

Read more
April 17, 2018

The inhibitor of apoptosis protein (IAP) antagonist Debio 1143 enhances the immune response to anti-PD1/L1 inhibitors in vitro and in…

Read more
April 16, 2018

Development of novel preclinical models of secondary resistance to the anti-CD37 antibody drug conjugate (ADC) IMGN529/DEBIO1562 in diffuse large B-cell…

Read more
January 23, 2018

Safety and efficacy of the selective FGFR inhibitor Debio 1347 in phase 1 study patients with fgfr genomically activated advanced…

Read more